{"title":"Symptom Clusters and Symptom Networks Analysis During Illness in Peripheral Facial Paralysis Patients: A Cross-Sectional Study","authors":"Luyi Huang, Xinrui Huang, Yan Xu, Min Xu","doi":"10.1111/coa.70102","DOIUrl":"10.1111/coa.70102","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>Identify the types of symptom clusters in patients with peripheral facial paralysis during the disease, construct symptom networks, explore core symptoms, and analyze the factors affecting the symptom scores of patients.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Study Design</h3>\u0000 \u0000 <p>A cross-sectional study.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>From December 2024 to May 2025, 283 patients with PFP in Zhejiang Province were assessed using the Memorial Symptom Assessment Scale (MSAS). Symptom clusters were extracted via exploratory factor analysis, and multiple linear regression was employed to examine factors associated with symptom burden. A symptom network was constructed using R software to identify core symptoms based on centrality indices. Network stability and accuracy were evaluated using nonparametric bootstrapping.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Five symptom clusters were identified: psychological, neurological, fatigue-related, gastrointestinal, and PFP-specific. Factors associated with higher symptom scores included age ≥ 70 years, House–Brackmann grade VI, autumn onset, no corticosteroid therapy, and initiation of acupuncture 7–14 days after onset. Centrality analysis revealed that difficulty concentrating (<i>s</i> = 1.041), feeling sad (<i>s</i> = 1.006), and worrying (<i>s</i> = 0.980) were core symptoms within the network.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Patients with PFP experience a significant symptom burden. Network analysis elucidates the complex interrelationships amongst symptoms and identifies difficulty concentrating, feeling sad, and worrying as central to the symptom experience. These findings provide a scientific basis for targeted symptom assessment and the development of personalised interventions aimed at core symptoms to improve patient quality of life.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":"51 4","pages":"555-564"},"PeriodicalIF":1.5,"publicationDate":"2026-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147484668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nasser Junedi, Akarsh Lal, Andrew J. Stefan, Swetha Reddy, Michael A. Carron
{"title":"Letter to Editor: Analysis of Vestibular Function Assessment Methods for Patients With Peripheral Vertigo Disease: A 5-Year Retrospective Study","authors":"Nasser Junedi, Akarsh Lal, Andrew J. Stefan, Swetha Reddy, Michael A. Carron","doi":"10.1111/coa.70109","DOIUrl":"10.1111/coa.70109","url":null,"abstract":"","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":"51 4","pages":"608-609"},"PeriodicalIF":1.5,"publicationDate":"2026-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147644046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Charles Picton, Joseph Rassam, Claire Lloyd-Davies, Mihir Gajre, Iain Mckay-Davies
{"title":"An Update on the Management of Otogenic Cerebral Sinus Thrombosis: A Systematic Review","authors":"Charles Picton, Joseph Rassam, Claire Lloyd-Davies, Mihir Gajre, Iain Mckay-Davies","doi":"10.1111/coa.70107","DOIUrl":"10.1111/coa.70107","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Otogenic cerebral sinus thrombosis (OCST) represents a rare but serious pathology. The medical and surgical treatment to achieve optimal patient outcomes remains unclear. This review assesses the published evidence of OCST to guide best practice.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A search of electronic databases Medline, Embase, Emacare, Cochrane and Clinicaltrials.gov was conducted from inception to November 2024. Eligible studies were identified and relevant findings extracted.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Sixty-eight papers, 43 case reports and 25 case series met the inclusion criteria with a total of 149 patients. 88.5% of patients underwent surgery, most commonly cortical mastoidectomy. 54.8% of patients received anticoagulation. Sixty-five percent of patients with reimaging had complete recannalisation of the sinus and 9.4% of patients experienced long term complications.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The combination of antibiotics, anticoagulation and surgery was associated with the most favourable outcome. Mastoidectomy and decompression of the sigmoid were commonly performed and largely safe. However, no additional benefit of incision and drainage of the sigmoid sinus was found and this was associated with a higher complication rate.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":"51 4","pages":"494-503"},"PeriodicalIF":1.5,"publicationDate":"2026-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147643999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Samuel A. Collazo, Kimberly A. Ramirez, Nareg H. Roubinian, Paniz Vafaei, Nancy Jiang, Cullen M. Taylor
{"title":"Association Between Nasal Septal Deviation and Estimated Pulmonary Artery Pressures—Scoping Review","authors":"Samuel A. Collazo, Kimberly A. Ramirez, Nareg H. Roubinian, Paniz Vafaei, Nancy Jiang, Cullen M. Taylor","doi":"10.1111/coa.70098","DOIUrl":"10.1111/coa.70098","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>Nasal septal deviation (NSD) is a common cause of chronic upper airway obstruction (UAO), and surgical correction via nasal septoplasty results in improvements in airflow. Multiple studies have been conducted to assess possible relationships between chronic UAO (including due to NSD) and cardiorespiratory function (such as pulmonary artery pressures). The objective of this scoping review is to identify and examine the current evidence on the potential relationship between nasal septal deviation, estimated mean pulmonary artery pressure (mPAP), and estimated pulmonary artery systolic pressure (ePASP) in patients who undergo nasal septoplasty.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Data Sources</h3>\u0000 \u0000 <p>PubMed, EMBASE, Ovid.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A scoping review was performed in accordance with the PRISMA Extension for Scoping Reviews guidelines.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Two independent reviewers screened 411 articles; 9 before-after studies met eligibility criteria for review inclusion. There was a total of 458 study participants, of which 395 underwent septoplasty and 63 were matched controls. All studies reported a statistically significant decrease between the pre-operative and post-operative estimated mPAP (<i>p</i> < 0.05) and/or ePASP (<i>p</i> < 0.001) in subjects who underwent nasal septoplasty. Two studies included control participants and reported a statistically significant difference between the pre-operative estimated mPAP of patients with NSD and controls (<i>p</i> < 0.001).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>This scoping review highlights the current evidence on the potential relationship between NSD, estimated mPAP, and ePASP in patients who undergo nasal septoplasty for NSD. Further studies of higher statistical and methodological quality are required to assess for cause-and-effect relationships and examine the potential link between chronic UAO and cardiorespiratory function.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":"51 4","pages":"488-493"},"PeriodicalIF":1.5,"publicationDate":"2026-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147442433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Keshav Kumar Gupta, Anthony Simons, Sean Mortimore, David Walker, Raguwinder Bindy Sahota, Mriganka De, Asit Arora, George Garas
{"title":"A Modified Delphi UK Consensus to Develop a Surgical Safety Checklist for Transoral Robotic Surgery","authors":"Keshav Kumar Gupta, Anthony Simons, Sean Mortimore, David Walker, Raguwinder Bindy Sahota, Mriganka De, Asit Arora, George Garas","doi":"10.1111/coa.70112","DOIUrl":"10.1111/coa.70112","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>The utilisation of transoral robotic surgery (TORS) has grown in popularity over recent years with wide applications for both benign and malignant disease. It is important to recognise that the introduction of robotic surgery inserts a new variable into an already error-prone healthcare service that has a high preventable adverse event rate. Surgical safety checklists (SSC) have been well established in recent years and demonstrated to improve outcomes and reduce complications. This study aims to introduce a novel SSC designed for use specifically in operating theatres for cases using TORS.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A modified Delphi process was utilised to define consensus for a proposed TORS specific SSC. An initial iteration was devised using a literature search. Experts with significant TORS experience rated each proposed item for potential inclusion using a Likert scale. The process was repeated until consensus was reached for all items.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Two rounds were completed with seven experts agreeing on various items to be included in the TORS specific SSC.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>This novel surgical safety checklist is the first developed specifically for use with TORS. It has been designed using robust Delphi methodology with several TORS experts from high-volume centres across the UK. The aim of the TORS SSC is to be used alongside the WHO SSC and requires ideally long-term and multi-centre adoption in order to validate its implementation.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":"51 4","pages":"591-599"},"PeriodicalIF":1.5,"publicationDate":"2026-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147716385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"NBI Interpretation After Radiotherapy: A Fundamental Limitation in This RCT","authors":"Regin William","doi":"10.1111/coa.70096","DOIUrl":"10.1111/coa.70096","url":null,"abstract":"","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":"51 4","pages":"606-607"},"PeriodicalIF":1.5,"publicationDate":"2026-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147364175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Morten Borg, Ole Hilberg, Rikke Ibsen, Anders Løkke
{"title":"Adherence and Effect on Allergy Medication Use in Allergic Rhinoconjunctivitis Patients Treated With House Dust Mite Allergen Immunotherapy—A Nationwide Cohort Study","authors":"Morten Borg, Ole Hilberg, Rikke Ibsen, Anders Løkke","doi":"10.1111/coa.70083","DOIUrl":"10.1111/coa.70083","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>House dust mite (HDM) allergy significantly impacts quality of life. Allergen immunotherapy (AIT), specifically sublingual immunotherapy (SLIT), is an effective treatment for HDM allergy, but adherence to SLIT remains a challenge. This study aimed to evaluate the impact of adherence to SLIT on the use of allergy medications, including antihistamines, nasal corticosteroids, and inhaled corticosteroids (ICS) in a real-world setting.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We conducted a nationwide cohort study using data from Denmark's comprehensive registries. Patients who initiated HDM SLIT between 2015 and 2020 were included, with follow-up through 2022. Adherent patients, defined as those obtaining at least 80% of the prescribed Defined Daily Dose (DDD) of SLIT, were compared to non-adherent patients. Medication use was tracked for antihistamines, nasal corticosteroids, and ICS. Statistical analyses, including Probit and generalised linear models, assessed the likelihood of obtaining medications and the quantity dispensed, adjusted for age and sex.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Of 950 patients, 456 (48%) were classified as adherent. Adherent patients showed significantly reduced usage of antihistamines (<i>p</i> < 0.001) and nasal corticosteroids (<i>p</i> < 0.001) compared to non-adherent patients. No significant differences were found in ICS use or dosage. Additionally, adherent patients were more likely to have higher education levels and be married or cohabiting.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Adherence to SLIT for HDM allergy is associated with reduced use of antihistamines and nasal corticosteroids. These findings emphasise the importance of SLIT adherence in managing HDM allergy and suggest that improving adherence could further reduce medication usage, improving patient outcomes in real-world settings.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":"51 3","pages":"394-400"},"PeriodicalIF":1.5,"publicationDate":"2026-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145899481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Piero Giuseppe Meliante, Edoardo Covelli, Giuseppe Cimino, Roger Altomari, Irene Fatuzzo, Chiara Filippi, Giorgio Bandiera, Antonella Polimeni, Antonio Greco, Marco de Vicentiis, Serena Bertin
{"title":"Dupixent's Efficacy in Cystic Fibrosis Related Chronic Rhinosinusitis With Nasal Polyposis: A Pilot Study","authors":"Piero Giuseppe Meliante, Edoardo Covelli, Giuseppe Cimino, Roger Altomari, Irene Fatuzzo, Chiara Filippi, Giorgio Bandiera, Antonella Polimeni, Antonio Greco, Marco de Vicentiis, Serena Bertin","doi":"10.1111/coa.70084","DOIUrl":"10.1111/coa.70084","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Cystic fibrosis (CF) patients often contend with chronic rhinosinusitis with nasal polyposis (CRSwNP), with higher relapse rates after surgery compared to non-CF individuals. CRSwNP has a significant impact on their quality of life and increases pulmonary infections risk. Traditional medical and surgical interventions are frequently inadequate. Dupixent is endorsed for persistent CRSwNP following conventional treatment in non-CF subjects; its effectiveness in CF patients remains unexplored considering that those patients are frequently affected by mixed endotypes of CRS with some type-2 features. This study delves into the assessment of Dupixent in CF-related CRSwNP and compares it with a matched control group.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This is a non-randomised single-centre trial enrolling CF patients and non-CF controls. SNOT-22 and NPS scores before, 1 and 6 months after therapy were documented.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Dupixent exhibited a significant reduction in SNOT-22 scores after 6 months in both CF and control groups (<i>V</i> = 21, <i>p</i> value = 0.031, both). While NPS scores showed non-significant improvement in CF, the control group experienced a notable reduction after 6 months (<i>V</i> = 10, both; <i>p</i> value = 0.10; <i>p</i> value = 0.034, respectively). No statistical differences were observed between CF and control groups in SNOT-22 and NPS scores after 6 months.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>This pilot study observed Dupixent's potential in managing CRSwNP in CF patients since SNOT-22 improvement was statistically significant and comparable to the non-CF patients. Although NPS scores improved without statistical significance, no differences emerged between CF and control groups. Therefore, Dupixent achieved comparable results between CF and non-CF patients suffering from CRSwNP.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":"51 3","pages":"409-417"},"PeriodicalIF":1.5,"publicationDate":"2026-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Association Between Rhinitis Subtypes and Migraine: A Comparative Clinical Study","authors":"Emiş Cansu Yaka, Özlem Yağız Aghayarov, Papatya Bayrak Değirmenci","doi":"10.1111/coa.70094","DOIUrl":"10.1111/coa.70094","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>This cross-sectional analysis aimed to determine and compare the prevalence, severity, and associated disability of migraine in individuals with allergic rhinitis (AR), non-allergic rhinitis (NAR), and healthy controls.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>In this prospective, cross-sectional study, 497 participants were enrolled: 200 with AR, 109 with NAR, and 188 controls. All participants underwent detailed assessment using the Total Rhinoconjunctivitis Score (TRS), Nasal Obstruction Symptom Evaluation (NOSE) scale, and were evaluated by a neurologist. Migraine was diagnosed according to ICHD-3 criteria. Migraine-related disability and impact were measured using the Migraine Disability Assessment (MIDAS) and Headache Impact Test-6 (HIT-6).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The prevalence of migraine was significantly higher in the combined rhinitis group (24.9%) compared to controls (16.0%) (OR = 1.75, <i>p</i> = 0.018). When analysed separately, the AR group had the highest migraine prevalence (26.0%), followed by the NAR group (22.9%). Patients with AR and migraine exhibited significantly higher MIDAS and HIT-6 scores than controls and those with NAR (<i>p</i> < 0.05), indicating greater disability. Both AR and NAR groups had significantly worse TRS and NOSE scores than controls (<i>p</i> < 0.001).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Rhinitis, particularly the allergic subtype, is significantly associated with a higher prevalence and greater severity of migraine. These findings highlight the importance of integrated management of nasal and headache symptoms.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":"51 3","pages":"449-457"},"PeriodicalIF":1.5,"publicationDate":"2026-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147621715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Muhammad Hammad Deewani, Muhammad Wasif Siddiqui, Hassan Danish, Muhammad Ozair Awan, Muhammad Sohail Awan, Ainulakbar Mughal, Abdul Basit Vardag, Hamdan Pasha, Haissan Iftikhar
{"title":"Is Mastoid Head Bandage Really Required in Patients Undergoing Middle Ear Surgery? A Randomised Control Trial","authors":"Muhammad Hammad Deewani, Muhammad Wasif Siddiqui, Hassan Danish, Muhammad Ozair Awan, Muhammad Sohail Awan, Ainulakbar Mughal, Abdul Basit Vardag, Hamdan Pasha, Haissan Iftikhar","doi":"10.1111/coa.70092","DOIUrl":"10.1111/coa.70092","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Middle ear surgery is a common procedure addressing various pathologies. Postoperative head bandaging has traditionally been used to provide support and prevent complications. However, its necessity remains controversial, with limited empirical evidence supporting its routine use.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>This randomised controlled trial (RCT) evaluated the necessity of head bandaging in middle ear surgery by comparing postoperative complications between a mastoid head bandage and a simple gauze dressing.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Eighty patients scheduled for middle ear surgery were randomly assigned to two groups: the Pressure Bandage group, where a crepe bandage was wrapped around the head, and the No Pressure Bandage group, where a gauze dressing was secured with Mefix tape. All surgeries were performed by a single otolaryngologist using standardised techniques, with the surgeon blinded to the dressing type. Postoperative complications, including hematoma, erythema, skin abrasion and wound infection, were recorded and compared.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The mastoid bandage group had a significantly higher incidence of forehead skin abrasions (6/40 vs. 0/40, <i>p</i> = 0.026). No significant differences were observed in hematoma or seroma formation, as neither group developed these complications.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Routine mastoid head bandaging does not appear necessary, as it does not reduce postoperative complications and may increase patient discomfort due to skin abrasions. Larger studies with longer follow-ups are recommended to strengthen these findings and guide clinical practice.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":"51 3","pages":"445-448"},"PeriodicalIF":1.5,"publicationDate":"2026-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146060441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}